Jun 1 2024 Abdelmonem et al., QJM: An International Journal of Medicine, doi:10.1093/qjmed/hcae070.076 Safety and Efficacy of N-Acetylcysteine as an Adjuvant Therapy in Critically Ill COVID-19 Patients Retrospective 80 ICU patients reporting no statistically significant differences with NAC treatment, however the actual results are not provided
The highly expressed ATF6 mediates tolerance to ferroptosis through transcriptional activation of PLA2G4A, and inhibition of ATF6 signaling by Ceapin-A7 enhances the effect of enzalutamide on CRPC xenograft growth [62]
(3) Takahashi Y
Packer has recently consulted for Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Cardiorentis, Celyad, Daiichi Sankyo, Gilead, NovoNordisk, Novartis, Relypsa, Sanofi, Takeda and ZS Pharma
W trakcie stosowania, u niektrych pacjentw zaobserwowano wystpowanie ostrego zapalenia trzustki